JW Pharmaceutical Corp. (formerly Choongwae Pharma) is one of the leading pharmaceutical companies in Korea with core competencies in antibiotics, IV solutions, and anti-cancer treatments. JW is currently exploring targeted therapies in oncology leveraging the collaborative research and development strengths from the JW Drug Discovery Center in Korea and the JW Theriac Corp in the US. This R&D pipeline is driven by our platform technologies that have the potential to eradicate cancer stem cells selectively through a molecularly targeted approach. ------- JW Group consists of JW Holdings, JW Pharmaceutical, JW Medical, JW ShinYak, JW Industrial, JW Life Science, and JW Creagene. JW possesses i) magnificent sales force (900 reps) for the hospital market, ii) strong relationships with managements of hospitals & and hospital pharmacies, iii) excellent rapport with key opinion leaders in endocrinology, gastroenterology, oncology, cardiology, nephrology, urology and the general surgery therapeutic areas. JW's total sales revenue of US $ 0.7 billion was derived from Korea and other several Asian countries in 2012
View Top Employees from JW Pharmaceutical CorporationWebsite | http://www.jw-pharma.co.kr |
Revenue | $436 million |
Employees | 236 (142 on RocketReach) |
Founded | 1945 |
Address | Top 2477, Seoul, Seoul, KR |
Phone | (822) 840-6777 |
Technologies |
JavaScript,
HTML,
Slack
+1 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Biotechnology, Antibiotics, Retail, Science and Engineering, I. V. solutions (Hospital Solutions), Health Care, Anti-cancer drugs, Pharmaceutical, Gastroenterology G. I., Urology |
Web Rank | 2 Million |
Keywords | Pharmaceutical Manufacturing, Biopharmaceuticals, Targeted Cancer Therapies, Oncology |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular JW Pharmaceutical Corporation employee's phone or email?
The JW Pharmaceutical Corporation annual revenue was $436 million in 2024.
Jae Chun is the CEO of JW Pharmaceutical Corporation.
142 people are employed at JW Pharmaceutical Corporation.
JW Pharmaceutical Corporation is based in Seoul, Seoul.
The NAICS codes for JW Pharmaceutical Corporation are [32, 3254, 32541, 325].
The SIC codes for JW Pharmaceutical Corporation are [283, 28].